Wholesale electricity costs as much as 267% more than it did five years ago in areas near data centers. That’s being passed ...

General anesthesia leads to better functional outcomes than conscious sedation in stroke patients with large vessel occlusion ...

Astria Therapeutics, Inc. acquired by BioCryst for $13 per share, with the deal set to finalize in 1Q26. Click here to read ...

Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating BRAFTOVI® (encorafenib ...

Median home price increases have slowed too, resulting in the median home price in the U.S. decreasing slightly to $400,000.

This study aimed to evaluate diurnal and seasonal trends in aerodynamic conductance over a grassland surface. A simple ...

Doctors need reliable ways to predict seizure risk after a first unprovoked seizure, to help guide diagnosis and treatment. This is especially important because a diagnosis of epilepsy can now be made ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed by ...

The five-year invasive disease-free survival (iDFS) rates were 85.5% in the Kisqali plus ET arm versus 81.0% in the ET alone arm, representing a clinically meaningful 4.5% improvement 1. These ...

Choose Your Own Adventure books are formatted so the reader must choose from two or three options to determine how the story ...